(Q33394465)

26 July 2017

New treatments for localized prostate cancer (English)

1 reference

26 July 2017

1 reference

Hedvig Hricak

5

0 references

Jonathan A. Coleman

object named as

Jonathan A Coleman

4

0 references

Michael J Zelefsky

object named as

Michael J Zelefsky

3

0 references

author name string

Michael Marberger

1

1 reference

26 July 2017

Peter R Carroll

2

1 reference

26 July 2017

Peter T Scardino

6

1 reference

26 July 2017

Lucien L Abenhaim

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

26 July 2017

1 reference

26 July 2017

72

1 reference

26 July 2017

6 Suppl

1 reference

26 July 2017

S36-43

1 reference

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Thermal ablation of prostate diseases: advantages and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Prostate cancer: cryotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Cryosurgical ablation of the prostate: high risk patient outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

EAU guidelines on prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

High-intensity focused ultrasound in the treatment of solid tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

High-Intensity Focused Ultrasound in the Treatment of Experimental Liver Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

High-Energy Shockwaves and Extracorporeal High-Intensity Focused Ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

A multiple focused probe approach for high intensity focused ultrasound based surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

The present and future role of photodynamic therapy in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Interstitial photodynamic laser therapy in interventional oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Interstitial photodynamic therapy for prostate cancer: a developing modality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Current clinical and preclinical photosensitizers for use in photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Photodynamic therapy: a new approach to prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

The Microenvironment Effect on the Generation of Reactive Oxygen Species by Pd−Bacteriopheophorbide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Vascular Targeted Photodynamic Therapy With Palladium-Bacteriopheophorbide Photosensitizer for Recurrent Prostate Cancer Following Definitive Radiation Therapy: Assessment of Safety and Treatment Response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Photodynamic therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Determination of the peak absorption wavelength and disaggregation kinetics of TOOKAD in vivo using dynamic, spatially resolved diffuse reflectance spectroscopy in a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Effects of TOOKAD-PDT on canine prostates pre-treated with ionizing radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Photodynamic therapy for urological malignancies: past to current approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Vascular-targeted photodynamic of prostate cancer phase with Tookad for recurrent prostate cancer following radiation therapy: initial clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

Assessment of Cutaneous Photosensitivity of TOOKAD (WST09) in Preclinical Animal Models and in Patients¶

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.506

10.1016/J.UROLOGY.2008.08.506

7 January 2021

Identifiers

DOI

1 reference

release_zy6uzgnjabc5ppxeyop2adlhdy

26 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zy6uzgnjabc5ppxeyop2adlhdy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference